Our study is the first to demonstrate that ECN inhibits cell migration, MMP-2 secretion, and invasion of human NSCLC cell lines, providing insights into the underlying mechanisms through regulating the EMT program in cancer cells. The gene discussed is MMP2; the disease is cancer.